A morphometric study of light-induced damage in transgenic rat models of retinitis pigmentosa

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 2, 2003, Pages 848-855

  Vaughan, Dana K ^a   Coulibaly, Sylvie F ^a   Darrow, Ruth M ^b   Organisciak, Daniel T ^b  

^a UNIVERSITY OF WISCONSIN OSHKOSH   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; LIGHT ABSORPTION; LIGHT DARK CYCLE; LIGHT EXPOSURE; LIGHT INTENSITY; MORPHOMETRICS; NONHUMAN; PATHOGENESIS; PHOTORECEPTOR; PHOTOSENSITIVITY; PHOTOTOXICITY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA ROD OUTER SEGMENT; RETINITIS PIGMENTOSA; TRANSGENE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; LIGHT; PIGMENT EPITHELIUM OF EYE; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL GANGLION CELLS; RETINITIS PIGMENTOSA; RHODOPSIN; ROD OUTER SEGMENTS;

EID: 0037309870     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0709     Document Type: Article

References (76)

1. Roberts JE. Ocular phototoxicity. J Photochem Photobiol B. 2001; 64:136-143.
2. Organisciak DT, Sarna T. Genetic, age and light induced degenerations of the retina and retinal pigment epithelium. In: Coohil TP, Valenzena DP, eds. Photobiology for the 21st Century. Overland Park, KS: Valdenmar Publishing; 2001;81-100.
3. Abler AS, Chang C-J, Fu J, Tso MOM, Lam TT. Photic injury triggers apoptosis of photoreceptor cells. Res Commun Mol Pathol Pharmacol. 1996;92:177-189.
4. Remé CE, Grimm C, Hafezi F, Marti A, Wenzel A. Apoptotic cell death in retinal degenerations. Prog Retinal Eye Res. 1998;17:443-464.
5. Hafezi F, Marti A, Munz K, Remé CE. Light-induced apoptosis: differential timing in the retina and pigment epithelium. Exp Eye Res. 1997;64:963-970.
6. Noell WK, Walker VS, Kang BS, Berman S. Retinal damage by light in rats. Invest Ophthalmol. 1966;5:450-473.
7. Williams TP, Howell WL. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci. 1983;24:285-287.
8. Grimm C, Wenzel A, Hafezi F, Yu S, Redmond TM, Remé CE. Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. Nat Genet. 2000;25:63-66.
9. Kutty RK, Kutty G, Wiggert B, Chader GJ, Darrow RM, Organisciak DT. Induction of heme oxygenase 1 in the retina by intense visible light: suppression by the antioxidant dimethylthiourea. Proc Natl Acad Sci USA. 1995;92:1177-1181.
10. Organisciak DT, Darrow RA, Barsalou L, Darrow RM, Lininger LA. Light-induced damage in the retina: differential effects of dimethylthiourea on photoreceptor survival, apoptosis and DNA oxidation. Photochem Photobiol. 1999;70:261-268.
11. Organisciak DT, Xie A, Wang H-M, et al. Adaptive changes in visual cell transduction protein levels: effect of light. Exp Eye Res. 1991; 53:773-779.
12. Li F, Cao W, Anderson RE. Protection of photoreceptor cells in adult rats from light-induced degeneration by adaptation to bright cyclic light. Exp Eye Res. 2001;73:569-577.
13. Penn JS, Williams TP. Photostasis: regulation of daily photon-catch by rat retinas in response to various cyclic illuminances. Exp Eye Res. 1986;43:915-928.
14. Penn JS, Naash ML, Anderson RE. Effect of light history on retinal antioxidants and light damage susceptibility in the rat. Exp Eye Res. 1987;44:779-788.
15. Mauget-Faysse M, Quaranta M, Francoz N, BenEzra D, Mauget-Faysse M. Incidental retinal phototoxicity associated with ingestion of photosensitizing drugs. Graefes Arch Clin Exp Ophthalmol. 2001;239:501-508.
16. Organisciak DT, Darrow RM, Barsalou L, Kutty RK, Wiggert B. Circadian-dependent retinal light damage in rats. Invest Ophthalmol Vis Sci. 2000;41:3694-3701.
17. Vaughan DK, Nemke JL, Fliesler SJ, Darrow RM, Organisciak DT. Evidence for a circadian rhythm of susceptibility to retinal light damage. Photochem Photobiol. 2002;75:547-553.
18. Rivolta C, Sharon D, DeAngelis MM, Dryja TP. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum Mol Genet. 2002;11:1219-1227.
19. Phelan JK, Bok D. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol Vis. 2000;6:116-124.
20. Dryja TP, Hahn LB, Cowley GS, McGee TL, Berson EL. Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci USA. 1991;88:9370-9374.
21. Sung CH, Davenport CM, Hennessey JC, et al. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci USA. 1991;88:6481-6485.
22. Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retinal Eye Res. 1998;17:175-205.
23. Portera-Cailliau C, Sung CH, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA. 1994;91:974-978.
24. Sahel JA, Mohand-Said S, Leveillard T, Hicks D, Picaud S, Dreyfus H. Rod-cone interdependence: implications for therapy of photoreceptor cell diseases. Prog Brain Res. 2001;131:649-661.
25. Bird AC. Investigation of disease mechanisms in retinitis pigmentosa. Ophthalmic Paediatr Genet. 1992;13:57-66.
26. Steinberg RH. Survival factors in retinal degenerations. Curr Opin Neurobiol. 1994;4:515-524.
27. Curcio C. Photoreceptor topography in ageing and age-related maculopathy. Eye 2001;15:376-383.
28. Ripps H. Cell death in retinitis pigmentosa: gap junctions and the "bystander" effect. Exp Eye Res. 2002;74:327-336.
29. Jacobson SG, Kemp CM, Cideciyan AV, Macke JP, Sung CH, Nathans J. Phenotypes of stop codon and splice site rhodopsin mutations causing retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1994;35:2521-2534.
30. Sandberg MA, Weigel-DiFranco C, Dryja TP, Berson EL. Clinical expression correlates with location of rhodopsin mutation in dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1995;36:1934-1942.
31. Sung CH, Tai AW. Rhodopsin trafficking and its role in retinal dystrophies. Int Rev Cytol. 2000;195:215-267.
32. Concepcion F, Mendez A, Chen J. The carboxyl-terminal domain is essential for rhodopsin transport in rod photoreceptors. Vision Res. 2002;42:417-426.
33. Green ES, Menz MD, LaVail MM, Flannery JG. Characterization of rhodopsin mis-sorting and constitutive activation in a transgenic rat model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2000;41:1546-1553.
34. Liu C, Li Y, Peng M, Laties AM, Wen R. Activation of caspase-3 in the retina of transgenic rats with the rhodopsin mutation S334ter during photoreceptor degeneration. J Neurosci. 1999;19:4778-4785.
35. Eversole-Cire P, Concepcion FA, Simon ML, Takayama S, Reed JC, Chen J. Synergistic effect of Bcl-2 and BAG-1 on the prevention of photoreceptor cell death. Invest Ophthalmol Vis Sci. 2000;41:1953-1961.
36. LaVail MM, Yasumura D, Matthes MT, et al. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci. 1998;39:592-602.
37. Drenser KA, Timmers AM, Hauswirth WW, Lewin AS. Ribozymetargeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1998;39:681-689.
38. Lau D, McGee LH, Zhou S, et al. Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci. 2000;41:3622-3633.
39. Green ES, Rendahl KG, Zhou S, et al. Two animal models of retinal degeneration are rescued by recombinant adeno-associated virusmediated production of FGF-5 and FGF-18. Mol Ther. 2001;3;507-515.
40. McGee Sanftner LH, Abel H, Hauswirth WW, Flannery JG. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol Ther. 2001;4:622-629.
41. Liang FQ, Aleman TS, Dejneka NS, et al. Long-term protection of retinal structure but not function using RAAV: CNTF in animal models of retinitis pigmentosa. Mol Ther. 2001;4:461-472.
42. Dryja TP, McGee TL, Reichel E, et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature. 1990; 343:364-366.
43. Kemp CM, Jacobson SG, Roman AJ, Sung CH, Nathans J. Abnormal rod dark adaptation in autosomal dominant retinitis pigmentosa with proline-23-histidine rhodopsin mutation. Am J Ophthalmol. 1992;113:165-174.
44. Berson EL, Rosner B, Sandberg MA, Dryja TP. Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His). Arch Ophthalmol. 1991;109:92-101.
45. Olsson JE, Gordon JW, Pawlyk BS, et al. Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron. 1992;9:815-830.
46. Machida S, Kondo M, Jamison JA, et al. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci. 2000;41:3200-3209.
47. LaVail MM, Yasumura D, Matthes MT, et al. Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. Proc Natl Acad Sci USA. 2000;97:11488-11493.
48. Naash MI, Hollyfield JG, al-Ubaidi MR, Baehr W. Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc Natl Acad Sci USA. 1993;90:5499-5503.
49. Wu TH, Ting TD, Okajima TI, et al. Opsin localization and rhodopsin photochemistry in a transgenic mouse model of retinitis pigmentosa. Neuroscience. 199;87:709-717.
50. Frederick JM, Krasnoperova NV, Hoffmann K, et al. Mutant rhodopsin transgene expression on a null background. Invest Ophthalmol Vis Sci. 2001;42:826-833.
51. Roof DJ, Adamian M, Hayes A. Rhodopsin accumulation at abnormal sites in retinas of mice with a human P23H rhodopsin transgene. Invest Ophthalmol Vis Sci. 1994;35:4049-4062.
52. Liu X, Wu TH, Stowe S, et al. Defective phototransductive disk membrane morphogenesis in transgenic mice expressing opsin with a mutated N-terminal domain. J Cell Sci. 1997;110:2589-2597.
53. Lewin AS, Drenser KA, Hauswirth WW, et al. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat Med. 1998;4:967-971.
54. Machida S, Chaudhry P, Shinohara T, et al. Lens epithelium-derived growth factor promotes photoreceptor survival in light-damaged and RCS rats. Invest Ophthalmol Vis Sci. 2001;42:1087-1095.
55. LaVail MM, Gorrin GM, Repaci MA, Thomas LA, Ginsberg HM. Genetic regulation of light damage to photoreceptors. Invest Ophthalmol Vis Sci. 1987;28:1043-1048.
56. LaVail MM, Gorrin GM, Repaci MA. Strain differences in sensitivity to light-induced photoreceptor degeneration in albino mice. Curr Eye Res. 1987;6:825-834.
57. Organisciak DT, Li M, Darrow RM, Farber DB. Photoreceptor cell damage by light in young Royal College of Surgeons rats. Curr Eye Res. 1999;19:188-196.
58. Naash ML, Peachy NS, Li Z-Y, et al. Light-induced acceleration of photoreceptor cell degeneration in transgenic mice expressing mutant rhodopsin. Invest Ophthalmol Vis Sci. 1996;37:775-782.
59. Wang M, Lam TT, Tso MOM, Naash ML. Expression of a mutant opsin gene increases the susceptibility of the retina to light damage. Vis Neurosci. 1997;14:55-62.
60. Nir I, Harrison JM, Liu C, Wen R. Extended photoreceptor viability by light stress in the RCS rats but not in the opsin P23H mutant rats. Invest Ophthalmol Vis Sci. 2001;42:842-849.
61. Heckenlively JR, Rodriguez JA, Daiger SP. Autosomal dominant sectoral retinitis pigmentosa: two families with transversion mutation in codon 23 of rhodopsin. Arch Ophthalmol. 1991;109:84-91.
62. Organisciak DT, Darrow RM, Barsalou L, Kutty RK, Wiggert B. Susceptibility to light-induced damage in transgenic rats with rhodopsin mutations. Invest Ophthalmol Vis Sci. 2003;44;486-492.
63. Rapp LM, Williams TP. A parametric study of retinal light damage in albino and pigmented rats. In: Williams TP, Baker BN, eds. The Effects of Constant Light on Visual Processes. New York: Plenum Press; 1980:133-159.
64. Grover S, Fishman GA, Brown J Jr. Patterns of visual field progression in patients with retinitis pigmentosa. Ophthalmology. 1998; 105:1069-1075.
65. Yoshii M, Murakami A, Akeo K, et al. Visual function in retinitis pigmentosa related to a codon 15 rhodopsin gene mutation. Ophthalmic Res. 1998;30:1-10.
66. Holopigian K, Seiple W, Greenstein VC, Hood DC, Carr RE. Local cone and rod system function in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2001;42:779-788.
67. Milam AH, De Castro EB, Smith JE, et al. Concentric retinitis pigmentosa: clinicopathologic correlations. Exp Eye Res. 2001;73:493-508.
68. Williams TP, Howell WL. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci. 1983;24:285-287.
69. Cideciyan AV, Hood DC, Huang Y, et al. Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man. Proc Natl Acad Sci USA. 1998;95:7103-7108.
70. Chan HL, Brown B. Investigation of retinitis pigmentosa using the multifocal electroretinogram. Ophthalmic Physiol Opt. 1998;18:335-350.
71. Seeliger M, Kretschmann U, Apfelstedt-Sylla E, Ruther K, Zrenner E. Multifocal electroretinography in retinitis pigmentosa. Am J Ophthalmol. 1998;125:214-226.
72. Vajaranant TS, Seiple W, Szlyk JP, Fishman GA. Detection using the multifocal electroretinogram of mosaic retinal dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology. 2002;109:560-568.
73. Li ZY, Jacobson SG, Milam AH. Autosomal dominant retinitis pigmentosa caused by the threonine-17-methionine rhodopsin mutation: retinal histopathology and immunocytochemistry. Exp Eye Res. 1994;58:397-408.
74. Milam AH, Fliesler SJ, Chaitin MH, Jacobson SG. Histopathology and immunocytochemistry of human retinal dystrophies. In: Anderson RE, Hollyfield JG, LaVail MM, eds. Retinal Degenerations. Boca Raton, FL: CRC Press; 1991:361-368.
75. Fariss RN, Li ZY, Milam AH. Abnormalities in rod photoreceptors, amacrine cells, and horizontal cells in human retinas with retinitis pigmentosa. Am J Ophthalmol. 2000;129:215-223.
76. Farrar GJ, Kenna PF, Humphries P. On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. EMBO J. 2002;21:857-864.